Cannell Capital LLC Eton Pharmaceuticals, Inc. Call Options Transaction History
Cannell Capital LLC
- $283 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ETON
# of Institutions
88Shares Held
13.8MCall Options Held
61.2KPut Options Held
33.1K-
Opaleye Management Inc. Boston, MA2.85MShares$54.8 Million10.18% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.94MShares$37.2 Million1.98% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.18MShares$22.6 Million0.69% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.1MShares$21.1 Million0.0% of portfolio
-
Westside Investment Management, Inc.494KShares$9.48 Million1.36% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $486M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...